Preoperative Evaluation and Management of the Patient Prior to Non-cardiac Surgery

  • Peter A. BleszynskiEmail author
  • Heather Shenkman
  • Hanna Z. Mieszczanska


With an aging population and advances in surgical techniques, an increasing number of patients with cardiac risk factors are undergoing non-cardiac surgery. The vast majority of surgeries are performed electively, allowing an interlude where strategies to reduce risk may be implemented. An appropriate preoperative evaluation when time allows is necessary to minimize the risk of potential cardiac complications and to optimize patient safety. The evaluation of these patients prior to non-cardiac surgery is one of the most common reasons for cardiology consultation. Cardiovascular complications are the leading cause of death within 30 days of non-cardiac surgery. We will discuss how to assess perioperative cardiac risk using clinical risk factors and type of surgery.


Preoperative Perioperative Intraoperative Cardiac Non-cardiac Surgery Clearance Risk Evaluation Assessment 


  1. 1.
    Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005;173:627–34.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Eagle KA, Baliga RR, editors. Practical cardiology: evaluation and treatment of common cardiovascular disorders. Philadelphia: Lippincott, Williams & Wilkins.Google Scholar
  3. 3.
    Devereaux PJ, Sessler DI. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med. 2015;373:2258–69.CrossRefPubMedGoogle Scholar
  4. 4.
    Dalby Kristensen S, Knuuti J, Saraste A, Anker S, Erik Bøtker H, De Hert S. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. Eur Heart J. 35(15):2383–431.
  5. 5.
    Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. J Am Coll Cardiol. 2014;64(22):e77–137.CrossRefPubMedGoogle Scholar
  6. 6.
    Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977;297:845–50.CrossRefPubMedGoogle Scholar
  7. 7.
    Gupta PK, Gupta H, Sundaram A, et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation. 2011;124:381–7.CrossRefGoogle Scholar
  8. 8.
    Patel AY, Eagle KA, Vaishnava P. Cardiac risk of noncardiac surgery. J Am Coll Cardiol. 2015;66:2140–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Bilimoria KY, Liu Y, Paruch JL, Zhou L, Kmiecik TE, Ko CY, Cohen ME. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. 2013;217:833–842.e3.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Duceppe E, Parlow J, Macdonald P, et al. Canadian Cardiovascular Society Guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Can J Cardiol. 2017;33:17–32.CrossRefPubMedGoogle Scholar
  11. 11.
    POISE Study Group, Devereaux PJ, Yang H, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371:1839–47.CrossRefGoogle Scholar
  12. 12.
    London MJ, Hur K, Schwartz GG, Henderson WG. Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA. 2013;309:231–8.CrossRefGoogle Scholar
  13. 13.
    Mcfalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351(27):2795–804.CrossRefPubMedGoogle Scholar
  14. 14.
    Priebe H-J. Preoperative cardiac management of the patient for non-cardiac surgery: an individualized and evidence-based approach. Br J Anaesth. 2011;107:83–96.CrossRefPubMedGoogle Scholar
  15. 15.
    Eacts CS, Germany CH, Rosenhek R, France EL, Rodriguez D, Tornos P, Vahanian A, Luis J. 2017 ESC / EACTS Guidelines for the management of valvular heart disease. The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European. Eur Heart J. 2017;38(36):2739–91.Google Scholar
  16. 16.
    Raju MG, Pachika A, Punnam SR, Gardiner JC, Shishehbor MH, Kapadia SR, Abela GS. Statin therapy in the reduction of cardiovascular events in patients undergoing intermediate-risk noncardiac, nonvascular surgery. Clin Cardiol. 2013;36:456–61.CrossRefPubMedGoogle Scholar
  17. 17.
    Rossini R, Musumeci G, Capodanno D, et al. Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry. Thromb Haemost. 2015;113:272–82.CrossRefPubMedGoogle Scholar
  18. 18.
    Rechenmacher SJ, Fang JC. Bridging anticoagulation primum non nocere. J Am Coll Cardiol. 2015;66:1392–403.CrossRefPubMedGoogle Scholar
  19. 19.
    Flaker GC, Theriot P, Binder LG, Dobesh PP, Cuker A, Doherty JU. Management of periprocedural anticoagulation a survey of contemporary practice. J Am Coll Cardiol. 2016;68(2):217–26. Scholar
  20. 20.
    Baron TH, Kamath PS, McBane RD. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med. 2013;368:2113–24.CrossRefPubMedGoogle Scholar
  21. 21.
    NLM C, Harding SA, Flapan AD, Graham C, Wild SH, Slack R, Pell JP, Newby DE, Scottish Coronary Revascularisation Register Steering Committee. Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv. 2010;3:236–42.CrossRefGoogle Scholar
  22. 22.
    Hawn MT, Graham LA, Richman JR, Itani KMF, Plomondon ME, Altom LK, Henderson WG, Bryson CL, Maddox TM. The incidence and timing of noncardiac surgery after cardiac stent implantation. J Am Coll Surg. 2012;214:658–66.CrossRefPubMedGoogle Scholar
  23. 23.
    Levine GN, et al. 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease. J Am Coll Cardiol. 2016;68:1082–115. Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Peter A. Bleszynski
    • 1
  • Heather Shenkman
    • 2
  • Hanna Z. Mieszczanska
    • 3
  1. 1.University of Rochester Medical Center/Internal MedicineRochesterUSA
  2. 2.CardiologyTarzanaUSA
  3. 3.University of Rochester Medical Center/CardiologyRochesterUSA

Personalised recommendations